Stay updated on Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Sign up to get notified when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.

Latest updates to the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page
- Check5 days agoChange DetectedThe page displays the study record, including its objectives, design, eligibility criteria, outcome measures, locations, and study documents.SummaryDifference63%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier was updated from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content and attachments with an access-restricted notice.SummaryDifference19%

Stay in the know with updates to Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.